Legal & General Group PLC Intra Cellular Therapies, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 145,653 shares of ITCI stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

145,653

Previous 141,991 2.58%

Holding current value

$10.7 Million

Previous $9.83 Million 1.53%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $237,151 - $292,374	3,662 Added 2.58%	145,653 $9.98 Million
Q1 2024 May 14, 2024	SELL	$64.37 - $75.65 $576,175 - $677,143	-8,951 Reduced 5.93%	141,991 $9.83 Million
Q4 2023 Feb 15, 2024	BUY	$46.37 - $73.65 $211,910 - $336,580	4,570 Added 3.12%	150,942 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $116,316 - $143,135	2,233 Added 1.55%	146,372 $7.62 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $3.17 Million - $3.85 Million	58,012 Added 67.36%	144,139 $9.13 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $241,688 - $314,470	5,518 Added 6.85%	86,127 $4.66 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $18,509 - $22,869	-420 Reduced 0.52%	80,609 $4.27 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $115,375 - $162,092	-2,702 Reduced 3.23%	81,029 $3.77 Million
Q2 2022 Aug 22, 2022	BUY	$43.0 - $65.64 $262,472 - $400,666	6,104 Added 7.86%	83,731 $4.78 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $441,752 - $708,012	11,403 Added 17.22%	77,627 $4.75 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $208,700 - $316,727	5,929 Added 9.83%	66,224 $3.47 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $387,490 - $573,275	13,492 Added 28.83%	60,295 $2.25 Million
Q2 2021 Aug 12, 2021	BUY	$29.3 - $44.5 $849 - $1,290	29 Added 0.06%	46,803 $1.91 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $197,274 - $253,061	6,405 Added 15.87%	46,774 $1.59 Million
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $4,341 - $5,992	-186 Reduced 0.46%	40,369 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $23,280 - $42,118	-1,322 Reduced 3.16%	40,555 $1.04 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $223,745 - $415,370	15,592 Added 59.32%	41,877 $1.08 Million
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $63,741 - $171,495	5,178 Added 24.53%	26,285 $404,000
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $20,995 - $111,313	2,892 Added 15.88%	21,107 $725,000
Q3 2019 Nov 13, 2019	BUY	$7.47 - $14.03 $16,217 - $30,459	2,171 Added 13.53%	18,215 $136,000
Q4 2018 Feb 15, 2019	BUY	$10.36 - $20.96 $14,234 - $28,799	1,374 Added 9.37%	16,044 $183,000
Q2 2018 Aug 10, 2018	SELL	$17.33 - $23.4 $14,938 - $20,170	-862 Reduced 5.55%	14,670 $259,000
Q1 2018 May 17, 2018	SELL	$15.16 - $25.49 $46,359 - $77,948	-3,058 Reduced 16.45%	15,532 $327,000
Q4 2017 Feb 13, 2018	BUY	$14.27 - $16.79 $265,279 - $312,126	18,590	18,590 $271,000

Others Institutions Holding ITCI

# of Institutions

400

Shares Held

87.2M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Intra Cellular Therapies, Inc. Transaction History